U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653282) titled 'Effect of GnRH Agonist in FET' on June 12.
Brief Summary: To evaluate the impact of single dose GnRH agonist administration as luteal phase support on pregnancy outcomes in frozen ICSI cycle
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
GnRH Agonist
Intervention:
DRUG: GnRH agonist
women undergoing frozen ICSI cycles receiving progesterone + GnRH agonist for luteal phase support.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Raafat Ahmed, Assiut University
Published by HT Digital Content Services with permission from Health Daily Digest....